Feline Nasopharyngeal Polyps

Feline nasopharyngeal polyps (FNPs) are benign, non-neoplastic inflammatory growths that arise from the mucous membrane lining of the middle ear cavity or the eustachian tube, extending into the nasopharynx and occasionally the external ear canal [2]. They represent the most common non-neoplastic lesion affecting the ear and nasopharynx in cats [4]. Although their exact cause remains incompletely understood, they can produce significant upper respiratory and neurological signs due to physical obstruction and local tissue involvement [2]. Young cats appear to be disproportionately affected, though polyps can be identified across a wide age range [1].

The precise etiology of feline nasopharyngeal polyps remains unclear, and multiple hypotheses have been proposed [2]. The leading theories include:

Chronic Inflammatory/Infectious Origin: Persistent upper respiratory tract infections—particularly those involving feline herpesvirus-1 (FHV-1) or feline calicivirus (FCV)—may trigger chronic mucosal inflammation of the eustachian tube or middle ear, stimulating aberrant proliferation of the lining epithelium [2]. Ascending infection from the nasopharynx to the eustachian tube is also proposed as an inciting pathway [2].

Congenital Origin: The high prevalence in young cats has led to the suggestion that some polyps may arise from congenital developmental anomalies of the first pharyngeal pouch or branchial arch derivatives, from which the eustachian tube and middle ear structures are embryologically derived [2][5]. The presence of polyps in cats under one year of age supports this theory.

Chronic Otitis Media: Pre-existing middle ear disease causing persistent mucosal irritation may provide a milieu for polyp formation [2]. Inflammatory exudate within the tympanic bulla, visible on imaging studies, is frequently associated with polyps [3][6].

Pathological Mechanism: Polyps typically originate from the ciliated respiratory epithelium of the eustachian tube or the tympanic cavity and grow along the path of least resistance—either descending into the nasopharynx (where they appear as a pedunculated mass arising from the roof of the pharynx) or extending laterally into the external ear canal [4][5]. Histologically, the polyps consist of a fibrovascular core covered by ciliated respiratory or squamous epithelium with variable inflammatory cell infiltration [6]. On post-contrast CT imaging, a characteristic rim-enhancement pattern is observed; histological analysis has demonstrated that this corresponds to a peripheral layer of highly vascularized inflamed connective tissue surrounding a less vascular central fibrous core [6]. Most polyps are unilateral, though bilateral cases are documented [3]. They arise within the tympanic cavity in the majority of cases (~68%), with a smaller proportion found exclusively in the nasopharynx (~18%) [6].

A systematic, multi-modal diagnostic approach is recommended for any cat with suspected FNPs [1].

Physical and Oropharyngeal Examination: A thorough anesthetized oropharyngeal examination is essential and often diagnostic; a pedunculated, smooth, pinkish-red mass may be visible at or behind the soft palate upon retraction [1][2]. Otoscopic examination should simultaneously assess the external ear canal for polyp extension and evaluate tympanic membrane integrity [1].

Imaging Studies:

• ·Radiography: A bulla radiographic series (ventrodorsal, lateral, and open-mouth rostrocaudal projections) can demonstrate soft tissue opacity within the tympanic bulla and sclerosis of bulla walls, indicating middle ear involvement. However, radiography has significant limitations in sensitivity for early or subtle disease [1].
• ·Computed Tomography (CT): CT is the imaging modality of choice for surgical planning and provides superior anatomical detail [3]. On pre-contrast CT, polyps appear mildly hypoattenuating to adjacent muscles and isoattenuating to soft tissue, homogeneous in internal architecture, and often with ill-defined borders [3]. Following intravenous contrast administration, polyps consistently display an oval shape, well-defined borders, homogeneous enhancement, and a characteristic peripheral rim enhancement pattern [3][6]. CT also permits assessment of bulla fluid, bony changes, and polyp extent—all critical for surgical decision-making [3][6].
• ·MRI: Provides excellent soft tissue contrast and is an alternative advanced imaging modality, particularly when CT findings are equivocal [1].

Otoscopy and Myringotomy: Direct otoscopy under anesthesia allows visualization of polyps within the horizontal ear canal and assessment of the tympanic membrane. If the membrane is intact and middle ear disease is suspected, myringotomy may be performed to sample middle ear content [1].

Biopsy and Histopathology: Due to the characteristic clinical and imaging appearance, a preoperative biopsy is not always required; however, histopathological confirmation is recommended in atypical cases to exclude neoplasia (e.g., carcinoma, lymphoma) or other lesions [1][4].

Laboratory Findings: Routine bloodwork is generally not diagnostically specific for FNPs. However, pre-anesthetic hematological and biochemical panels are indicated to assess overall health, particularly in cats with prolonged illness:

• ·Complete Blood Count (CBC): May show a mild leukocytosis (elevated WBC) and neutrophilia consistent with concurrent bacterial infection or chronic inflammation, though these are non-specific findings.
• ·Serum Biochemistry: Generally within normal limits. If concurrent chronic disease or dehydration is present, mild elevations in BUN and CREA may be noted; ALB may be low-normal in cats with chronic poor nutritional intake.
• ·Cytology of aural exudate: If otitis externa is present, cytological examination of ear discharge may reveal bacteria, yeast, or inflammatory cells, guiding antimicrobial therapy in the perioperative period [1]. No definitive laboratory biomarker specific to FNPs has been identified in the current literature.

Surgical Removal — Primary Treatment:

Surgical excision is the definitive treatment for FNPs [1][4].

• ·

  Traction-Avulsion (Simple Traction): This is the most common initial technique, performed by grasping the polyp stalk with forceps and applying steady, gentle traction until the polyp is avulsed at its base [4]. It is minimally invasive, can be performed during the anesthetized diagnostic examination, and has a good short-term success rate. However, it carries a notable risk of recurrence because the origin within the bulla is not addressed [4].

• ·

  Traction-Avulsion with Tympanic Bulla Curettage: Following polyp avulsion, the tympanic cavity is entered through the external ear canal and the bulla is curetted to remove residual polyp tissue and inflammatory debris. This approach reduces recurrence rates compared to simple avulsion [4].

• ·

  Per-Endoscopic Transtympanic Traction (PETT): A minimally invasive technique using video-otoscopy to visualize the bulla contents through the tympanic membrane, allowing directed traction and curettage under direct visualization. This technique has demonstrated excellent outcomes with low recurrence and minimal complications [4].

• ·

  Ventral Bulla Osteotomy (VBO): This open surgical approach involves making an incision over the ventral aspect of the tympanic bulla, opening the bone, and thoroughly removing polyp tissue and inflammatory exudate from within the cavity. VBO is the most complete surgical option and is strongly indicated when [1][4]:

  • ·Signs of otitis media are present
  • ·Advanced imaging reveals significant bulla involvement
  • ·Simple traction has failed or polyp recurrence has occurred

Management of Otitis Media/Interna: When concurrent middle ear disease or Horner's syndrome is present, VBO is the preferred surgical approach, as it allows complete débridement of the bulla [1]. Post-operative neurological signs (Horner's syndrome, head tilt) may temporarily worsen following VBO but typically resolve over weeks to months [1][4].

Medical Management:

• ·Corticosteroids: A short post-operative course of prednisolone (1–2 mg/kg orally once daily, tapering over 2–4 weeks) following traction-avulsion has been advocated to reduce mucosal inflammation and may decrease recurrence rates [4].
• ·Antibiotics: Perioperative or post-operative antimicrobial therapy is indicated in cats with concurrent bacterial otitis media or secondary respiratory infection. Selection should ideally be guided by culture and sensitivity of aural or nasopharyngeal samples [1].
• ·Supportive Care: Nutritional support, fluid therapy, and management of secondary rhinitis or tracheitis as clinically indicated.

Feline nasopharyngeal polyps carry an overall excellent prognosis; the condition is not directly life-threatening, and mortality attributable solely to FNPs is extremely low in cats receiving appropriate treatment [1][4].

Recurrence Rates by Treatment Modality:

• ·Simple traction-avulsion alone is associated with relatively higher recurrence rates; early literature reported recurrence in approximately 50% of cats treated by traction alone without addressing the bulla [4].
• ·Traction-avulsion combined with tympanic bulla curettage or PETT significantly reduces recurrence, with long-term resolution achieved in the majority of cases [4].
• ·Ventral bulla osteotomy (VBO) provides the most durable outcomes, with low recurrence rates and is considered the gold standard when middle ear involvement is confirmed [1][4].

Neurological Complications: Horner's syndrome is a recognized complication following both the polyp itself and surgical intervention (particularly VBO). In most cases, post-operative Horner's syndrome and vestibular signs resolve spontaneously within weeks to a few months, though permanent deficits can rarely occur [1][2][4].

Overall Outcome: With appropriate surgical management, the vast majority of affected cats experience complete resolution of clinical signs and return to normal quality of life [4]. The condition is benign and non-metastatic; malignant transformation has not been reported [2][4]. Specific peer-reviewed survival statistics (e.g., median survival times) are not reported in the referenced literature, reflecting the benign and non-fatal nature of this condition.

Currently, no specific preventive measures have been validated for feline nasopharyngeal polyps, largely because the precise etiology remains incompletely understood [2].

Infection Control: Given the proposed association between chronic upper respiratory tract infections (particularly FHV-1 and FCV) and polyp development, routine vaccination against these pathogens is theoretically beneficial and represents sound general preventive medicine [2]. Reducing viral exposure through proper hygiene, isolation of new cats, and avoiding overcrowding in multi-cat environments or shelters may reduce the infectious burden that could contribute to chronic nasopharyngeal and eustachian tube inflammation.

Early Detection and Prompt Treatment: Early recognition and treatment of chronic upper respiratory disease, otitis media, and recurrent ear infections may theoretically reduce the chronicity of mucosal inflammation that predisposes to polyp formation. Owners of cats with recurrent ear disease or chronic respiratory signs should pursue veterinary evaluation promptly [1][2].

Congenital Cases: Because a congenital origin is postulated for some polyps—particularly in young cats—no practical prevention strategy exists for this subset [2][5].

Monitoring: Following surgical treatment, regular recheck examinations (including otoscopic and oropharyngeal assessment) are recommended to detect recurrence early, enabling timely re-intervention before signs become severe [1][4].